Who owns VERTEX PHARMACEUTICALS INC / MA?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VRTX from SEC Form 13F filings across 1,786 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 1,786 institutions disclosed 239.0M shares of VERTEX PHARMACEUTICALS INC / MA worth $125.02B — about 94.3% of shares outstanding; the largest disclosed holder is Capital World Investors. Source: SEC Form 13F filings, parsed by EvidInvest.
1,786
13F holders
$125.02B
value, 2026 filers
94.3%
of shares outstanding (239.0M sh)
176
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of VRTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Capital World Investors | 26.0M | $13.58B | 1.6% | 10.2% | -0.6% |
| 2 | BlackRock, Inc. | 23.8M | $12.44B | 0.2% | 9.4% | -1.3% |
| 3 | Capital Research Global Investors | 17.8M | $9.31B | 1.3% | 7% | -8.6% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 16.6M | $8.68B | 0.2% | 6.5% | +0.1% |
| 5 | STATE STREET CORP | 12.0M | $6.29B | 0.2% | 4.7% | +1.3% |
| 6 | Invesco Ltd. | 8.3M | $4.33B | 0.3% | 3.3% | +3.0% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 6.1M | $3.17B | 0.2% | 2.4% | +1.1% |
| 8 | JPMORGAN CHASE & CO | 5.7M | $3.00B | 0.2% | 2.2% | -12.7% |
| 9 | Capital International Investors | 5.1M | $2.65B | 0.5% | 2% | +7.8% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9M | $2.59B | 0.1% | 2% | +1.3% |
| 11 | FRANKLIN TEMPLETON INC | 4.5M | $2.45B | 0.5% | 1.8% | +33.3% |
| 12 | LOOMIS SAYLES & CO L P | 3.6M | $1.89B | 2.5% | 1.4% | -7.7% |
| 13 | JENNISON ASSOCIATES LLC | 3.6M | $1.87B | 1.1% | 1.4% | +19.2% |
| 14 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3.4M | $1.80B | 0.3% | 1.4% | +11.4% |
| 15 | WELLINGTON MANAGEMENT GROUP LLP | 3.4M | $1.76B | 0.3% | 1.3% | +3.6% |
| 16 | MORGAN STANLEY | 3.3M | $1.71B | 0.1% | 1.3% | +1.1% |
| 17 | BANK OF AMERICA CORP /DE/ | 3.1M | $1.64B | 0.1% | 1.2% | +2.9% |
| 18 | ALLIANCEBERNSTEIN L.P. | 3.0M | $1.57B | 0.5% | 1.2% | -0.3% |
| 19 | NORTHERN TRUST CORP | 2.6M | $1.34B | 0.2% | 1% | +3.2% |
| 20 | VICTORY CAPITAL MANAGEMENT INC | 2.6M | $1.34B | 0.7% | 1% | +17.7% |
| 21 | AMERIPRISE FINANCIAL INC | 2.3M | $1.18B | 0.2% | 0.9% | -13.1% |
| 22 | GOLDMAN SACHS GROUP INC | 2.2M | $1.15B | 0.1% | 0.9% | -11.3% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.9M | $981.1M | 0.1% | 0.7% | -8.1% |
| 24 | Legal & General Group Plc | 1.8M | $964.3M | 0.2% | 0.7% | -1.4% |
| 25 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.7M | $906.2M | 0.1% | 0.7% | +0.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.